Where’s Menactra? No Word From Sanofi-Aventis As User Fee Date Passes

The estimated user fee deadline for the meningococcal conjugate vaccine was Oct. 18. FDA says the vaccine is not currently a licensed product; Sanofi-Aventis has not announced an action by the agency.